corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 11253

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Menkes DB, Jureidini JN, Mansfield PR.
Skepticism about antidepressants for under 18s
BMJ Rapid Response 2007 Aug 22; epub
http://www.bmj.com/cgi/eletters/335/7615/329#175023


Abstract:

Hickie asserts that antidepressant drugs can benefit those under 18 (1). The best evidence supporting this assertion comes from a meta-analysis by Bridge et al (2) concluding that the benefits of newer antidepressants outweigh the harms posed by treatment-induced suicidality. This conclusion warrants skepticism for several reasons…


Notes:

Free full text

Comment on:
Hickie I. Is depression overdiagnosed? No. BMJ 2007;335(7615):329 (18 August)

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








What these howls of outrage and hurt amount to is that the medical profession is distressed to find its high opinion of itself not shared by writers of [prescription] drug advertising. It would be a great step forward if doctors stopped bemoaning this attack on their professional maturity and began recognizing how thoroughly justified it is.
- Pierre R. Garai (advertising executive) 1963